Classification of peptides according to their blood-brain barrier influx

Protein and Peptide Letters

Volumn 22, Issue 9, 2015, Pages 768-775

  Stalmans, Sofie ^a   Gevaert, Bert ^a   Wynendaele, Evelien ^a   Nielandt, Joachim ^a   Tré, Guy De ^a   Peremans, Kathelijne ^a   Burvenich, Christian ^a   De Spiegeleer, Bart ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Blood brain barrier; Classification; Influx; Peptides; Permeability; Unified response

Indexed keywords

PEPTIDE;

ARTICLE; BLOOD BRAIN BARRIER; CALCULATION; CLASSIFICATION; CONTROLLED STUDY; INFLUX RATE CONSTANT; PEPTIDE ANALYSIS; PERMEABILITY BARRIER; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; CAPILLARY PERMEABILITY; CHEMISTRY; KINETICS; METABOLISM; PHYSIOLOGY; PROTEIN DATABASE;

BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DATABASES, PROTEIN; KINETICS; PEPTIDES;

EID: 84939811434     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866522666150622101223     Document Type: Article

References (29)

1. Craik, D. J.; Fairlie, D. P.; Liras, S.; Price, D. The Future of Peptidebased Drugs. Chem. Biol. Drug Des., 2013, 81, 136-147.
2. Sato, A. K.; Viswanathan, M.; Kent, R. B.; Wood, C. R. Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotech., 2006, 17, 638-642.
3. Antosova, Z.; Mackova, M.; Kral, V.; Macek, T. Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol., 2009, 27, 628-635.
4. McGonigle, P. Peptide therapeutics for CNS indications. Biochem. Pharmacol., 2012, 83, 559-566.
5. Alavijeh, M. S.; Chishty, M.; Qaiser, M. S.; Palmer, A. M. Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery. Neurotherapeutics, 2005, 2, 554-571.
6. Wegener, G.; Rujescu, D. The current development of CNS drug research. Int. J. Neuropsychopharmacol., 2013, 16, 1687-1693.
7. Chandler, D. J. Something's got to give: psychiatric disease on the rise and novel drug development on the decline. Drug Discov. Today, 2013, 18, 202-206.
8. Banks, W. A.; Kastin, A. J. Permeability of the blood-brain barrier to neuropeptides: the case for penetration. Psychoneuroendocrinology, 1985, 10, 385-399.
9. Banks, W. A.; Kastin, A. J. Saturable transport of peptides across the blood-brain barrier. Life Sci., 1987, 41, 1319-1338.
10. Kastin, A. J.; Pan, W. In: Progress in Drug Research; Prokai, L.; Prokai-Tatrai, K., Eds.; Birkhäuser Verlag: Basel, 2003, pp. 79-100.
11. Van Dorpe, S.; Bronselaer, A.; Nielandt, J.; Stalmans, S.; Wynendaele, E.; Audenaert, K.; Van De Wiele, C.; Peremans, K.; Hsuchou, H.; De Tré, G.; De Spiegeleer, B. Brainpeps: the bloodbrain barrier peptide database. Brain Struct. Funct., 2012, 217, 687-718.
12. Smith, Q. R. In: Models for Assessing Drug Absorption and Metabolism; Borchardt, R. T.; Smith, P. L.; Wilson, G., Eds.; Plenum Press: New York, 1996, pp. 299.
13. Van Dorpe, S.; Adriaens, A.; Polis, I.; Peremans, K.; Van Bocxlaer, J.; De Spiegeleer, B. Analytical characterization and comparison of the blood-brain barrier permeability of eight opioid peptides. Peptides, 2010, 31, 1390-1399.
14. Dogrukol-Ak, D.; Tore, F.; Tuncel, N. Passage of VIP/PACAP/Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects. Curr. Pharm. Des., 2004, 10, 1325-1340.
15. Stalmans, S.; Wynendaele, E.; Bracke, N.; Gevaert, B.; D'Hondt, M.; Peremans, K.; Burvenich, C.; De Spiegeleer, B. Chemical-Functional Diversity in Cell-Penetrating Peptides. Plos One, 2013, 8, e71752.
16. Stalmans, S.; Wynendaele, E.; Bracke, N.; Knappe, D.; Hoffmann, R.; Peremans, K.; Polis, I.; Burvenich, C.; De Spiegeleer, B. Blood-Brain Barrier Transport of Short Proline-Rich Antimicrobial Peptides. Protein Peptide Lett., 2014, 21, 399-406.
17. Deguchi, Y.; Terasaki, T. In: Handbook of Biologically Active Peptides; Kastin, A. J., Ed.; Elsevier Academic Press: Burlington, 2006, pp. 1443-1448.
18. Stalmans, S.; Bracke, N.; Wynendaele, E.; Gevaert, B.; Peremans, K.; Burvenich, C.; De Spiegeleer, B. Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo. [EPub ahead of print].
19. Egleton, R. D.; Witt, K. A.; Davis, T. P. In: Handbook of Biologically Active Peptides; Kastin, A. J., Ed.; Elsevier Academic Press: Burlington, 2006, pp. 1429-1434.
20. Kastin, A. J.; Pan, W. Blood-Brain Barrier and Feeding: Regulatory Roles of Saturable Transport Systems for Ingestive Peptides. Curr. Pharm. Des., 2008, 14, 1615-1619.
21. Banks, W. A.; Schally, A. V.; Barrera, C. M.; Fasold, M. B.; Durham, D. A.; Csernus, V. J.; Groot, K.; Kastin, A. J. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Nat. Acad. Sci. USA, 1990, 87, 6762-6766.
22. Banks, W. A.; Kastin, A. J. In: Progress in Brain Research; Ermisch, A.; Landgraf, R.; Rühle, H.-J., Ed.; Elsevier Science: Amsterdam, 1992, pp. 139-147.
23. Pan, W.; Kastin, A. J. Why study transport of peptides and proteins at the neurovascular interface. Brain Res. Rev., 2004, 46, 32-43.
24. Egleton, R. D.; Davis, T. P. Bioavailability and Transport of Peptides and Peptide Drugs into the Brain. Peptides, 1997, 18, 1431-1439.
25. Smith, M. W.; Gumbleton, M. Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. J. Drug Target., 2006, 14, 191-214.
26. Tamai, I.; Tsuji, A. Transporter-Mediated Permeation of Drugs Across the Blood-Brain Barrier. J. Pharm. Sci., 2000, 89, 1371-1388.
27. Kastin, A. J.; Pan, W.; Maness, L. M.; Banks, W. A. Peptides crossing the blood-brain barrier: some unusual observations. Brain Res., 1999, 848, 96-100.
28. 1-38Across the Blood-Brain Barrier. J. Pharmacol. Exp. Ther., 1993, 267, 690-696.
29. Banks, W. A.; Kastin, A. J.; Akerstrom, V.; Jaspan, J. B. Radioactively iodinated cyclo (His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis. Am. J. Physiol. Endoc. M, 1993, 264, E723-E729.